This part.. where we consider the likelihood of either 100 million to 300 million in sells from the aqusition date through the following 4 qtrs. From Yahoo board (if I remember correctly) one of the key posters (who also was right about the buy-out and called ENDO a leading candidate a couple months back) said 100 m is no prob; tifwiw.
"Under the terms of the merger agreement, an affiliate of Endo will promptly commence a tender offer to acquire all of the outstanding shares of NuPathe's common stock for $2.85 per share in cash and the right to receive contingent cash consideration payments of up to $3.15 per share if specified net sales milestones for NuPathe's migraine treatment ZECUITY are achieved. The contingent cash consideration payments will not be publicly traded. The contingent cash consideration payments can be summarized as follows:
·
$2.15 per share if net sales of ZECUITY exceed $100 million during any four-quarter period prior to the ninth anniversary of the first commercial sale of ZECUITY; and
·
An additional $1.00 per share if net sales of ZECUITY exceed $300 million during any four-quarter period prior to the ninth anniversary of the first commercial sale of ZECUITY.
The affiliate of Endo that consummates the tender offer will enter into a separate Contingent Cash Consideration Agreement with American Stock Transfer & Trust Company as Paying Agent to provide for the payment of the contingent cash consideration payments. The stockholders of NuPathe will be third party beneficiaries under this agreement. Pursuant to the terms of the Contingent Cash Consideration Agreement, Endo will guarantee the obligations of its affiliate to make the contingent cash consideration payments.
Following the successful completion of the tender offer, Endo will acquire all remaining shares not tendered in the tender offer through a second-step merger at the same price and the obligation to make the same contingent cash consideration payments as was deliverable to those stockholders tendering their shares in the tender offer. The tender offer and withdrawal rights are expected to expire at 12:00 midnight, New York City time on the 20th business day after the launch of the tender offer, unless extended in accordance with the merger agreement and the applicable rules and regulations of the Securities and Exchange Commission.
The consummation of the tender offer is subject to various conditions, including a minimum tender of a majority of outstanding NuPathe shares on a fully diluted basis, the expiration or termination of any applicable waiting periods under applicable competition laws, and other customary conditions. The board of directors of NuPathe unanimously approved the transaction.
The transaction is expected to be completed in early 2014.
Recent PATH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 10:16:28 PM
- UiPath State of the Automation Professional Report Highlights 2024 as the Year of AI Integration • Business Wire • 09/16/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 08:24:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2024 08:17:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/11/2024 08:20:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/06/2024 09:13:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2024 08:14:27 PM
- Broadcom Down 10% Post-Earnings, UiPath Up 8%; Qualcomm Eyes Intel Assets; Salesforce Acquires Own Company • IH Market News • 09/06/2024 11:59:00 AM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 09/05/2024 11:19:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 08:17:42 PM
- UiPath Reports Second Quarter Fiscal 2025 Financial Results • Business Wire • 09/05/2024 08:10:00 PM
- UiPath Chief Financial Officer Ashim Gupta Takes on Expanded Role as Chief Operating Officer • Business Wire • 09/05/2024 08:10:00 PM
- UiPath Appoints S. Somasegar to its Board of Directors • Business Wire • 09/05/2024 08:10:00 PM
- U.S. Index Futures Steady Amid Labor Data Anticipation; Oil Prices Rise • IH Market News • 09/05/2024 10:13:05 AM
- UiPath Unveils Partner Sponsors for FORWARD, the Largest Global Event for Automation and AI Practitioners • Business Wire • 09/04/2024 02:30:00 PM
- UiPath to Participate in the Piper Sandler Growth Frontiers Conference • Business Wire • 09/03/2024 08:10:00 PM
- UiPath Named a Leader in Everest Group Digital Interaction Intelligence Products PEAK Matrix® Assessment 2024 • Business Wire • 08/26/2024 12:33:00 PM
- UiPath, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before August 19, 2024 to Discuss Your Rights - PATH • PR Newswire (US) • 08/19/2024 09:45:00 AM
- UiPath, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before August 19, 2024 to Discuss Your Rights - PATH • PR Newswire (US) • 08/15/2024 09:45:00 AM
- UiPath Recognized as a Leader in the 2024 Gartner Magic Quadrant for Robotic Process Automation • Business Wire • 08/12/2024 03:56:00 PM
- Lost Money on UiPath, Inc.(PATH)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 08/12/2024 09:30:00 AM
- UiPath Announces Second Quarter Fiscal 2025 Financial Results Conference Call • Business Wire • 08/08/2024 08:10:00 PM
- The Gross Law Firm Reminds UiPath Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 19, 2024 - PATH • PR Newswire (US) • 08/08/2024 09:45:00 AM
- UiPath Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PATH • PR Newswire (US) • 08/06/2024 02:00:00 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM